Molina Arturo Md sold 2,718 shares of Protagonist Therapeutics, Inc at $124.65 for −$339k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Medical Officer
Chief Medical Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$338,798.70Shares × reported price
Shares traded
2,718Common Stock
Price per share
$124.65Reported price. Read footnotes for ranges.
% of reported position traded
3.23%This security and ownership context
Holdings after
81,397Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 17, 2026, 8:29 PM ET2-day reporting delay
Accession
0001104659-26-129244Code S · Transaction 405057
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 84,115 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PTGX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTGX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −11%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.